Focus on...

Fundamental Research
News 23 October 2024

Thesis award: a biosynthetic pathway for the anticancer drug Etoposide

On 16 October, the third IFPEN-ANRT thesis prize was awarded to Jennifer Perrin for her thesis in the field of life and health sciences entitled “Approches d'ingénierie métabolique en levure pour la sécurisation de la production de l'anticancéreux Etoposide en Région Centre-Val de Loire” (Yeast metabolic engineering approaches to secure the production of the anticancer drug Etoposide in the Centre-Val de Loire region), defended on 31 January 2023 at Tours University. This thesis was conducted within the framework of a CIFRE agreement signed with the SME Axyntis. The company, the award winner and her thesis supervisors explain the significance of this research.

FUNDAMENTAL RESEARCH, THE BUILDING BLOCK FOR FUTURE INNOVATION

Objectives pursued, scientific challenges to be overcome, partnerships proposed: watch a video on IFPEN’s fundamental research strategy.

To find out more

Research in a few figures

  • 1,095
    R&I engineers and technicians
  • 30%
    of budget dedicated to fundamental research
  • 9
    disciplinary fields
  • 15
    active fundamental research framework agreements